Maternal KIR and Fetal HLA-C Genes in Recurrent Miscarriages

计划入组 400 人 · 首次发布于 2005 年 9 月 16 日

Preeclampsia and Defective Placentation in Oocyte Donation: Importance of HLA-C and KIR

计划入组 2,325 人 · 首次发布于 2025 年 9 月 17 日

PREDICTIVE IMMUNOLOGICAL STUDY OF RECURRENT ABORTIONS AND IMPLANTATION FAILURE

计划入组 200 人 · 首次发布于 2019 年 8 月 9 日

MC2 TCR T cells therapy (Erasmus Medical Center)

anti-KRAS

Brenetafusp

C & C Oxygen Company

United States

Buchanan C Michael

United States

DENVER NEPHROLOGISTS P C

United States

BriaCell Secures New Zealand Patent for HLA-Matched Whole-Cell Cancer Immunotherapy Technology

FDA Approves First-in-Human Trial for Novel CAR-T Therapy Targeting Neuroblastoma

Chromophobe Renal Cell Carcinoma Shows Immune-Cold Environment and Poor Response to Checkpoint Inhibitors